Though the two molecules target the same receptor and share a similar chemical structure, there is enough laboratory evidence to distinguish their effects on the receptor, hormone levels, appetite control and scientific applications
If you need a concrete product example, Peptide Warehouse USA lists a CJC-1295 (NO-DAC) + Ipamorelin Blend for research catalog purposes, which is relevant when protocol design involves combined peptide systems rather than ipamorelin alone
Fix: Align expectations: aim for 0.51 % body-weight loss/week
Participants taking GLP-1s were also 19% less likely to die from any cause during nearly 40 months of follow-up
* Correction added on July 25, 2022, after first online publication of July 7, 2022: The Clinical Trial Registration number has been corrected from (NCT03215043) to (NCT03928249)
Still, its worth it for the health benefits and the chance to live a healthier life